Finance

Lists
CORONA:NSE
Corona Remedies Ltd
₹2,545.70
+0.45%
(+11.50) 1D
Nov 9, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CORONA...
Open
₹2,525.00
High
₹2,719.30
Low
₹2,500.30
Mkt. cap
155.31B
Avg. vol.
40.01K
Volume
166.76K
Dividend
0.39%
Quarterly dividend
₹2.50
Ex-dividend date
Jun 19, 2026
P/E ratio
75.21
52-wk high
₹2,719.30
52-wk low
₹1,336.60
EPS
₹33.85
No. of employees
5K
Open
₹2,525.00
High
₹2,719.30
Low
₹2,500.30
Mkt. cap
155.31B
Avg. vol.
40.01K
Volume
166.76K
Dividend
0.39%
Quarterly dividend
₹2.50
Ex-dividend date
Jun 19, 2026
P/E ratio
75.21
52-wk high
₹2,719.30
52-wk low
₹1,336.60
EPS
₹33.85
No. of employees
5K
News stories
From web sources and news partners
About Corona Remedies Ltd
CEO-
Employees5.15K
Founded2004
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Nov 2, 2026
Fiscal period
Q2 2027
₹9.86 / ₹10.00
-1.40%miss
Revenue / Est. (INR)
4.41B / 4.27B
+3.22%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
3.42B
3.53B
4.22B
4.41B
Cost of goods sold
602.70M
772.40M
775.20M
805.10M
Cost of revenue
602.70M
772.40M
775.20M
805.10M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
959.40M
2.14B
1.22B
1.24B
Operating expense
2.08B
2.24B
2.65B
2.80B
Total operating expenses
2.69B
3.01B
3.43B
3.60B
Operating income
737.10M
522.70M
798.90M
808.90M
Other non operating income
22.40M
-58.90M
31.50M
24.80M
EBT including unusual items
552.10M
547.40M
803.60M
807.50M
EBT excluding unusual items
743.10M
550.20M
803.60M
807.50M
Income tax expense
139.40M
94.10M
202.50M
204.40M
Effective tax rate
25.25%
17.19%
25.20%
25.31%
Other operating expenses
1.03B
-7.00M
1.30B
1.40B
Net income
412.70M
453.30M
601.10M
603.10M
Net profit margin
12.05%
12.84%
14.23%
13.67%
Earnings per share
-
7.41
9.83
9.86
Interest and investment income
-
70.60M
-
-
Interest expense
-16.60M
-11.10M
-26.90M
-27.50M
Net interest expenses
-16.60M
59.50M
-26.90M
-27.50M
Depreciation and amortization charges
94.50M
102.90M
132.40M
150.60M
EBITDA
838.56M
608.10M
884.30M
950.40M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps